These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 7039441)
1. Immunologic response to liver cell allografts. Toledo-Pereyra LH; Gordon DA; MacKenzie GH Am Surg; 1982 Jan; 48(1):28-31. PubMed ID: 7039441 [TBL] [Abstract][Full Text] [Related]
2. Orthotopic liver transplantation. Various immunosuppressive regimens to improve survival. Toledo-Pereyra LH; Bandlien KO; MacKenzie GH; Gordon DA Am Surg; 1984 May; 50(5):258-63. PubMed ID: 6372562 [TBL] [Abstract][Full Text] [Related]
3. Can clamping of splenic vessels prevent abrupt increase of portal vein pressure and migration of transplanted hepatocytes to the liver after intrasplenic hepatocyte transplantation? Kim WH; Lee JH; Han SU; Wang HJ; Kim MW Hepatogastroenterology; 1998; 45(24):2425-9. PubMed ID: 9951937 [TBL] [Abstract][Full Text] [Related]
4. Hepatocyte transplantation into the lung for treatment of acute hepatic failure in the rat. Then P; Sandbichler P; Erhart R; Dietze O; Klima G; Vogel W; Margreiter R Transplant Proc; 1991 Feb; 23(1 Pt 1):892-3. PubMed ID: 1990717 [TBL] [Abstract][Full Text] [Related]
5. Significance of central perivenulitis in pediatric liver transplantation. Abraham SC; Freese DK; Ishitani MB; Krasinskas AM; Wu TT Am J Surg Pathol; 2008 Oct; 32(10):1479-88. PubMed ID: 18708942 [TBL] [Abstract][Full Text] [Related]
6. Influence of hepatocyte-rich liver cell mixture and liver fibroblasts on prolonging graft islet survival in rats without immunosuppressive drugs. Soto-Montenegro L; Zugasti-Murillo A; Rollán E; Alvarez Y; Alvarez G; Jara-Albarrán A Exp Clin Endocrinol Diabetes; 2004 Nov; 112(10):580-6. PubMed ID: 15578333 [TBL] [Abstract][Full Text] [Related]
7. Studies of liver repopulation using the dipeptidyl peptidase IV-deficient rat and other rodent recipients: cell size and structure relationships regulate capacity for increased transplanted hepatocyte mass in the liver lobule. Rajvanshi P; Kerr A; Bhargava KK; Burk RD; Gupta S Hepatology; 1996 Mar; 23(3):482-96. PubMed ID: 8617428 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of indoleamine dioxygenase in rat liver allografts using a high-efficiency adeno-associated virus vector does not prevent acute rejection. Laurence JM; Wang C; Zheng M; Cunningham S; Earl J; Tay SS; Allen RD; McCaughan GW; Alexander IE; Bishop GA; Sharland AF Liver Transpl; 2009 Feb; 15(2):233-41. PubMed ID: 19177450 [TBL] [Abstract][Full Text] [Related]
9. Multiple intrasplenic hepatocyte transplantations in the dalmatian dog. Dunn TB; Kumins NH; Raofi V; Holman DM; Mihalov M; Blanchard J; Law WR; Rastellini C; Benedetti E Surgery; 2000 Feb; 127(2):193-9. PubMed ID: 10686985 [TBL] [Abstract][Full Text] [Related]
10. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation. Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002 [TBL] [Abstract][Full Text] [Related]
11. Treatment of cirrhosis and liver failure in rats by hepatocyte xenotransplantation. Nagata H; Ito M; Cai J; Edge AS; Platt JL; Fox IJ Gastroenterology; 2003 Feb; 124(2):422-31. PubMed ID: 12557148 [TBL] [Abstract][Full Text] [Related]
12. Hepatocyte transplantation in rats with decompensated cirrhosis. Kobayashi N; Ito M; Nakamura J; Cai J; Gao C; Hammel JM; Fox IJ Hepatology; 2000 Apr; 31(4):851-7. PubMed ID: 10733539 [TBL] [Abstract][Full Text] [Related]
13. Hepatocyte transplantation for the treatment of human disease. Strom SC; Chowdhury JR; Fox IJ Semin Liver Dis; 1999; 19(1):39-48. PubMed ID: 10349682 [TBL] [Abstract][Full Text] [Related]
14. Prevention of orthotopic liver allograft rejection in rats with a short-term brequinar sodium therapy. Analysis of intragraft cytokine gene expression. Shirwan H; Cosenza CA; Wang HK; Wu GD; Makowka L; Cramer DV Transplantation; 1994 Apr; 57(7):1072-80. PubMed ID: 8165706 [TBL] [Abstract][Full Text] [Related]
15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
16. Liver allograft rejection in sensitized recipients. Observations in a clinically relevant small animal model. Nakamura K; Murase N; Becich MJ; Furuya T; Todo S; Fung JJ; Starzl TE; Demetris AJ Am J Pathol; 1993 May; 142(5):1383-91. PubMed ID: 8494042 [TBL] [Abstract][Full Text] [Related]
18. The effects of transplantation of hepatocytes cultured with insulin on acute liver failure induced by 90% hepatectomy in the rat. Wang X; Zhao X; Andersson R Eur J Surg; 1995 Jul; 161(7):475-81. PubMed ID: 7488660 [TBL] [Abstract][Full Text] [Related]
20. Suppression of acute and chronic rejection by hepatocyte growth factor in a murine model of cardiac transplantation: induction of tolerance and prevention of cardiac allograft vasculopathy. Yamaura K; Ito K; Tsukioka K; Wada Y; Makiuchi A; Sakaguchi M; Akashima T; Fujimori M; Sawa Y; Morishita R; Matsumoto K; Nakamura T; Suzuki J; Amano J; Isobe M Circulation; 2004 Sep; 110(12):1650-7. PubMed ID: 15364799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]